IL-32γ enhances TNF-α-induced cell death in colon cancer

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3

(2011) Mi H. Park et al.   IMMUNOLOGY

Programmed necrosis: backup to and competitor with apoptosis in the immune system

(2011) Jiahuai Han et al.   NATURE IMMUNOLOGY

IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals

(2011) J H Oh et al.   ONCOGENE

Paradoxical effects of constitutive human IL-32  in transgenic mice during experimental colitis

(2010) J. Choi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Guggulsterone induces apoptosis in colon cancer cells and inhibits tumor growth in murine colorectal cancer xenografts

(2009) Min Ji An et al.   CANCER LETTERS

PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers

(2009) S. Wee et al.   CANCER RESEARCH

Miz1 is a signal- and pathway-specific modulator or regulator (SMOR) that suppresses TNF- -induced JNK1 activation

(2009) J. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A proinflammatory cytokine interleukin-32β promotes the production of an anti-inflammatory cytokine interleukin-10

(2008) Jeong-Woo Kang et al.   IMMUNOLOGY

Identification of the most active interleukin-32 isoform

(2008) Ji-Da Choi et al.   IMMUNOLOGY

Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells

(2008) C. Wilson et al.   MOLECULAR CANCER THERAPEUTICS

Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function

(2008) A. M. Marcondes et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA